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ABSTRACT
Objectives  To develop and validate a quantitative 
radiographic scoring system, the Ghent University Scoring 
System (GUSS), with better ability to detect progression 
over a shorter period of time in erosive osteoarthritis (OA) 
of the interphalangeal (IP) ﬁ  nger joints compared with the 
existing anatomic phase scoring system.
Methods  Thirty IP ﬁ  nger joints showing erosive features 
at baseline or follow-up were selected from 18 patients 
with erosive hand OA. Posteroanterior radiographs of 
these joints obtained at baseline, 6 and 12 months—
totalling 90 images—were used for the study. All joints 
were ﬁ  rst scored according to the original anatomic 
phase scoring system. Erosive progression and signs 
of repair or remodelling were then scored by indicating 
the proportion of normal subchondral bone, subchondral 
plate and joint space on an 11-point rating scale (range 
0–100 with 10 unit increases). Inter- and intrareader 
reproducibility was studied using intraclass correlation 
coefﬁ  cients (ICCs). Based on the within-variance of 
two readers, the smallest detectable change (SDC) 
was calculated and allowed identiﬁ  cation of joints with 
changes above the SDC as ‘progressors’.
Results  Longitudinal inter-reader ICC scores rated well 
for all variables and the total score (ICC 0.86–0.93). To 
identify ‘real’ change over background noise, a change 
of at least 40 units on the total score (range 0–300) 
over 12 months (SDC 0–12:36.0), and 50 units over 6 
months (SDC 0–6:47.6) had to be present. 60% of the 
30 joints were identiﬁ  ed as ‘progressors’ over 6 months 
compared with 33.3% with the classical anatomical 
scoring system, and 70% versus 56.6%, respectively, 
over 12 months.
Conclusion  GUSS, is a reliable method to score 
radiographic change over time in erosive IP OA and 
detects more progression over a shorter period of time 
than the classical scoring system.
INTRODUCTION
Erosive osteoarthritis (OA) is an inﬂ  ammatory 
subset of interphalangeal (IP) ﬁ  nger joint OA, in 
which marked tissue destruction is followed by 
episodes during which the affected tissues are 
remodelled.1–4 Although erosive hand OA remains 
a debated entity, hand joints exhibiting a subchon-
dral bone collapse can be qualiﬁ  ed as ‘erosive’ hand 
OA joints. Radiological imaging is currently the 
standard method to study hand OA progression 
and erosive IP ﬁ  nger joint OA needs to be studied 
apart from non-erosive hand OA.5 The progres-
sive nature and the successive pathological changes 
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in osteoarthritic IP ﬁ  nger joints have been docu-
mented in detail.6
On the radiographs, erosive changes in the 
affected IP joints include the disappearance of 
parts of the joint space followed by, or concur-
rently with, the appearance of substantial osteo-
lytic areas in the subchondral bone and the 
subchondral plate. Alternatively, a subchondral 
plate collapse without complete disappearance 
of joint space may occur. Finally, destruction and 
enlargement of the joint space of the affected IP 
joint will be seen. This entire destruction of a non-
eroded IP joint may occur within a few months. 
Destructive phases, however, are always followed 
by repair or remodelling. Then, new irregular scle-
rotic subchondral plates are formed and a new 
joint space becomes visible, subchondral osteo-
lytic areas gradually disappear and huge osteo-
phytes are formed. No further evolution is seen in 
remodelled IP joints.
A system to score the progression of hand OA 
was designed based on the consecutive pathologi-
cal phases recognised in the course of the disease: 
a non-erosive OA joint (‘S’ or stationary OA joint) 
can enter the ‘J’ phase when the joint space disap-
pears, and then the ‘E’ phase when manifest erosive 
changes occur. Next, the affected IP joints show 
signs of repair or remodelling and the ‘R’ phase 
ensues.6 Numerical values were attributed to the 
different phases and the system then allowed sig-
niﬁ  cant progression to be recorded over   1–3-year 
periods.7–9
Critical appraisal of this categorical classiﬁ  -
cation system, however, unveiled a few short-
comings. First, current studies10 of radiographic 
data in patients with erosive IP OA show that 
minor and unmistakable changes could be seen 
within only 6 months of follow-up. The ana-
lytical system based on changes in categorical 
variables did not allow evaluation of the obvi-
ous changes occurring in IP joints classiﬁ  ed in the 
same anatomical phase—for example, a ‘J’ phase, 
an ‘E’ phase or even an ‘R’ phase. Moreover, the 
sequence of anatomical phases ‘N–S–J–E–R’ was 
acknowledged as a continuous deterioration 
with the ‘R’ phase being the worst situation with 
the highest pathological score.6 The observation 
of tissue remodelling in an ‘E’ joint progressing 
to an ‘R’ phase, however, indicated that destruc-
tive events came to an end, enabling subsequent 
tissue repair. Comparable tissue repair was seen 
in other forms of destructive arthritis when 
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catabolic events in the affected tissues were blocked with 
tumour necrosis factor blocking agents.11 Rather than being 
a worsening, remodelling should be considered and valued as 
a process of repair.
These reﬂ  ections encouraged us to optimise the categorical 
scoring system for progression by scoring the extent of path-
ological changes in the subchondral bone architecture, the 
subchondral bone plate and the synovial joint space, and com-
putation of an overall score for the affected joints.
MATERIAL AND METHODS
Radiographs: selection and blinding
Posteroanterior radiographs of the hands were obtained from 
18 people who had the ‘erosive’ type of OA of their IP ﬁ  nger 
joints and in whom other rheumatic conditions were excluded. 
These subjects had participated in a 1-year randomised, placebo-
  controlled, double-blind study to evaluate the potential of a 
tumour necrosis factor α blocking monoclonal antibody to slow 
down destruction and to promote remodelling of the affected 
ﬁ  nger joints.10 Accordingly, the condition for inclusion of sub-
jects in this therapeutic trial was the presence of one or more 
IP joints presenting the destructive ‘J’ or ‘E’ phases described 
previously.6
Radiographs of the IP joints were obtained at baseline, and 
after 6 and 12 months of follow-up. Then 30 IP ﬁ  nger joints 
showing further structural change, either destructive or repara-
tive, were selected, comprising a collection of 90 images which 
were randomly numbered 1 to 90. Apart from 18 ‘E’ phase target 
Figure 1  (A) Erosive changes and (B) remodelling on radiographs of six different interphalangeal joints taken at 6-month intervals. (A) 1: Disappearance 
of the joint space. 2: Destruction of the subchondral bone plate; osteolytic events in and near the subchondral plate lead to a rufﬂ  ed aspect of the 
subchondral plate. 3: Appearance of osteolytic areas in the subchondral bone. 4: Both the destruction of the subchondral plate and the osteolytic events 
in the subchondral bone area cause the generation of a widened pseudo-joint with irregular margins. (B) 5: Disappearance of the osteolytic areas in the 
subchondral bone area. 6: Reconstruction of the subchondral bone plate, which did not necessarily appear as a denser radio-opaque zone. 
7: Reappearance of a radiotranslucent area recognised as the reconstructed joint space.
joints, the radiographs presented one IP ﬁ  nger joint in the ‘S’ 
(non-erosive OA) phase, nine IP joints in the ‘J’ phase in which 
the joint space had disappeared and two remodelled ‘R’ IP ﬁ  nger 
joints.6
Score of erosive changes
Three variables were selected to grade the severity of the radio-
graphic changes: the proportions of the subchondral bone show-
ing osteolytic areas, the relative amount of the subchondral bony 
plate resorbed, and the disappearance of the normal joint space, 
either by an entire loss of the articular cartilage or by a complete 
destruction of the subchondral bone plate and the appearance of 
a pseudo-joint (ﬁ  gure 1A).
Score of remodelling
Some of the ‘E’ IP joints showed apparent signs of remodel-
ling during follow-up. Changes typical of tissue repair in these 
IP joints (‘E/R’ joints) were a disappearance of the osteolytic 
areas in the subchondral bone and so a recovery of ordinary 
subchondral bone, and also a reconstruction of the subchon-
dral bone plate. The latter was accompanied by the reappear-
ance of a distinct joint space. Remodelling was thus scored 
in the same three areas retained to grade erosive changes 
(ﬁ  gure 1B).
Detailed assessment of changes on the radiographs
Proportions of the subchondral bone area with normal/abnor-
mal-looking bone architecture were assessed in a rectangle 
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Progression of selected IP joints through categorical 
anatomical phases
All joints were scored according to the ‘in-house’ anatomical 
phase scoring system.6 ‘J’, ‘E’ or ‘R’ phases were assigned to the 
pictures of the selected 30 IP joints at baseline and after 6 and 12 
months of follow-up.
Statistics
Descriptive clinical and radiographic data were recorded at base-
line for the 18 patients selected. Data were summarised using 
the mean for normally distributed, continuous variables, and the 
median (minimum – maximum) for non-normally distributed 
variables. Cross-sectional radiographic data are presented for 
each reader (reader 1, reader 2) and the mean for both readers 
at baseline, 6 and 12 months. Longitudinal data are presented as 
the mean change score for both readers. Intra- and inter-reader 
reliability were assessed using intraclass correlation coefﬁ  cients 
(ICCs). Estimates of the 95% CI were calculated. Reproducibility 
of the categorical scoring system was evaluated by the percent-
age of absolute agreement between readers and readings and by 
unweighted κ statistics.
Responsiveness, the degree of progression of radiological joint 
damage above the measurement error, is best determined by the 
smallest detectable change (SDC = ±1.96 × SD∆ (change scores 
between raters)/(√k × √2), where ‘k’ represents the number of read-
ings or raters used for the actual analyses of a   trial.13 Calculating 
these cut-off values allowed us to express the results in simple cat-
egories such as the number of patients who improved, worsened, 
or remained stable. Sensitivity to change of the scoring system 
was estimated on the basis of differences between baseline and 
12 months using the standardised response mean (SRM = mean 
change/SD of change). All statistical analyses were performed 
using the statistical software package SPSS version 15.0.
square of which the height equalled the width of the joint space. 
The joint space was positioned in the centre of this square  (ﬁ  gure 
2A,B; row 2). Areas of disruption or loss of trabecular structure 
are marked on the radiographs (ﬁ  gure 2A,B; row 3). The sub-
chondral bone plate is identiﬁ  ed as a regular linear bone margin 
ﬂ  anking the joint space (ﬁ  gure 2E,F; row 2). In an IP joint that 
had lost its joint space, a subchondral plate was deﬁ  ned as a 
regular radio-opaque linear structure within the position of the 
original joint space (ﬁ  gure 2D; row 2). Joint space was recog-
nised as a radiotranslucent area bordered by two subchondral 
plates   (ﬁ  gure 2E,F; row 3).
An atlas with 50 radiographs representing changes of sub-
chondral bone (10 images), subchondral bone plate and syno-
vial joint space (40 images) of IP ﬁ  nger joints is available as an 
online supplementary ﬁ  le. Changes in the architecture of the 
subchondral bone area, in the subchondral plate and in the 
synovial space, are clearly indicated by illustrative line draw-
ings and comments included in an additional online supplemen-
tary text ﬁ  le.
Computation of the changes in IP joints in ‘J’, ‘E’ and ‘E/R’ 
phases
The 90 images were read in a single order to evaluate the 
extent of the pathological changes in the three selected areas 
of the IP ﬁ  nger joint. Proportional amounts of normal tissue 
still present during a ‘J’ or ‘E’ phase or that reappeared dur-
ing remodelling (‘E/R’ and ‘R’ phase) were recorded on an 
11-point rating scale (range 0–100 with 10 unit increases) 
(ﬁ  gure 3). The sum of the three separate scores constitutes 
the total IP joint score. Equal weight was attributed to each 
of the subdomains. In addition, a longitudinal analysis was 
done after arranging the results of the readings in the correct 
sequence.12
Figure 2  Detailed assessment of normality and pathology on the radiographs in ‘E’ and ‘E/R’ joints. Scores represent the proportion of 
(remaining) normal structure for each domain. (A,B) Changes in subchondral bone. Areas of osteolytic activity are marked and calculated 
proportions of normal bone remaining are presented: score subchondral bone = 100 – proportion of abnormal osteolytic bone. (C–F) Changes 
in subchondral bone plate (row 2) and in joint space (row 3); row 2: subchondral bone plates represented by white line; row 3: joint space was 
recognised as a radiotranslucent area bordered with two subchondral plates, which is not the case in 3C and D. Proportions of subchondral bone 
plate and of joint space still identiﬁ  able are presented in the ﬁ  gures. Scores presented in the ﬁ  gures are proportions of normal subchondral bone 
plate and of normal joint space.
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Mean scores for each subdomain and the total score for each 
reader and reading are shown in table 1.
Cross-sectional intra- and inter-reader reproducibility of 
scores was calculated on the data from the readings of the radio-
graphs in a single order. ICC values and their 95% CI were high 
for both readers, ranging from 0.73 to 0.99. The lowest ICC was 
obtained by both readers for the subdomain subchondral bone. 
The ICCs (95% CI) for each reader are shown in table 1. Inter-
reader ICC values are 0.71 for the subchondral bone, 0.85 for the 
subchondral plate, 0.88 for the joint space and 0.89 for the total 
score, exhibiting a good reproducibility for all scores.
The longitudinal ICC values (95% CI) between repeated 
scores of changes between baseline and 6 months, and baseline 
and 12 months, after unblinding for time, are given in table 2 
for each reader and between readers. ICC values are excellent 
for reader 2 on all variables ranging from 0.97 to 0.99. Reader 1 
scores well for subchondral plate, joint space and the total score 
with ICC of 0.91, 0.88 and 0.85 for change between baseline 
and 6 months, respectively, and 0.91, 0.94 and 0.96 for change 
between baseline and 12 months, respectively. ICC values for 
subchondral bone scores are moderate for reader 1 (table 2). 
Inter-reader ICC scores are good for subchondral plate, joint 
space and total score and good for subchondral bone over a time 
interval of 12 months.
Reliability was also assessed for the scores (90 radiographs) 
according to the original, ordinal anatomic phase scoring sys-
tem. The percentage of absolute agreement between the readers 
is 93.6% (κ = 0.92). The intrareader reliability for both readers 
was excellent with a percentage of absolute agreement of 95.9% 
(κ = 0.95) for reader 1 and 98.2% (κ = 0.98) for reader 2.
Responsiveness
The mean differences with the SD (MΔ ± 1SD) and calculated 
SDC are shown in table 2. The SDC for the total score over 6 
and 12 months was 47.6 and 36.0 units, meaning that a change 
obtained over 6 months of 50 units or more, and over 12 months 
of 40 or more on the total score can be interpreted as a real 
change. The cumulative probability plot in ﬁ  gure 4 shows that a 
number of IP joints (n = 12) showed signiﬁ  cant remodelling over 
12 months (change of total score greater than the SDC, in this 
case ≥36). Similarly, nine IP joints progressed to more erosive dis-
ease. Nine joints remained stable. The new scoring system, the 
Ghent University Scoring System (GUSS), allowed classiﬁ  cation 
of 70.0% of joints as ‘progressors’. In the same way, an absolute 
change in total score exceeding an SDC of 47.6 between base-
line and 6 months in 18 IP ﬁ  nger joints allowed 60% of these 
joints to be classiﬁ  ed as ‘progressors’.
RESULTS
Study materials
Ninety radiographs obtained from 18 patients (15 female, three 
male), all Caucasian, with erosive osteoarthritis of the distal IP 
and/or proximal IP ﬁ  nger joints, were selected. The mean age at 
baseline was 60.8 years (SD 8.7) and the disease duration was 
11.3 years (range 1.1–40.9). On average, 12.5 of patients’ 16 IP 
joints showed osteoarthritic changes, with respectively 5, 0.5, 3 
and 4 joints in the ‘S’, ‘J’, ‘E’ and ‘R’ phase. The IP joints of the 
thumb were excluded.
Intra- and inter-reader reliability
Reading the 90 selected radiographs enabled the readers to judge 
proportions of subchondral bone, subchondral bone plate and 
joint space in IP ﬁ  nger joints that were destroyed or remodelled. 
Table 1  Cross-sectional analysis (N=90): mean scores for each subdomain and for the total score for each 
reader and for each reading of the radiographs read in single order and reliability analysis by ICC (95% CI)
Variable Reader
Mean (SD) (range)
Intra-reader reliability 
ICC (95% CI)
Inter-reader reliability 
ICC (95% CI)
Reading 1 Reading 2 Reading 1 – reading 2 Reading 1 – reading 1
SCh bone 1 67.0 (20.8) (10–100) 71.2 (18.5) (20–100) 0.73 (0.62 to 0.82) 0.71 (0.60 to 0.80)
2 71.0 (22.0) (20–100) 71.3 (21.7) (20–100) 0.98 (0.97 to 0.99)
SCh plate 1 57.2 (27.3) (0–100) 59.3 (26.3) (0–100) 0.89 (0.83 to 0.92) 0.85 (0.78 to 0.90)
2 62.6 (24.7) (0–100) 62.1 (24.2) (0–100) 0.98 (0.97 to 0.99)
JT space 1 35.8 (34.2) (0–100) 36.8 (33.7) (0–100) 0.90 (0.85 to 0.93) 0.88 (0.83 to 0.92)
2 43.0 (35.5) (0–100) 42.9 (35.6) (0–100) 0.99 (0.99 to 0.99)
Total score 1 160.0 (69.0) (10–300) 167.3 (66.3) (20–300) 0.92 (0.88 to 0.95) 0.89 (0.84 to 0.93)
2 176.6 (69.2) (20–300) 176.3 (68.2) (20–300) 0.99 (0.99 to 0.99)
Reader 1, GV; reader 2, RW.
ICC, intraclass coefﬁ  cient of correlation; JT, joint; SCh, subchondral.
Figure 3  Evaluation of the extent of the pathological changes in 
subchondral bone architecture (SCBO), the presence/absence of 
subchondral bone plate (SCPL) and of synovial joint space (JTSP). The 
changes in these three variables were recorded on an 11-point rating 
scale (range 0–100 with 10 unit increases). Top series: IP joint going 
through ‘E’ phase. Bottom series: remodelling IP joint.
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occurred in 11 (36.7%) and seven (23.3%) of the target joints, 
respectively.
Disease progression over 12 months was detected in up to 
21 (70.0%) of the 30 target joints. More erosive disease or obvi-
ous remodelling occurred in nine and 12 of these 21 IP ﬁ  nger 
joints. The previous anatomical phase scoring system allowed 
17 (56.7%) of these IP joints to be classiﬁ  ed as progressors. Eight 
and nine IP joints, respectively, were recognised as more erosive 
or showed signs of repair. GUSS detected signiﬁ  cantly more pro-
gression after 6 months (McNemar test: p = 0.008). Progressive 
changes over longer periods—that is, 12 months, allowed more 
IP joints to move to a subsequent anatomical phase, resulting in 
comparable power of both scoring systems.
Sensitivity to change
The standardised response means (SRM = mean change/SD of 
change) were rather low, ranging from 0.19 to 0.32 for reader 1 
(SRM = 0.21, 0.24, 0.32 and 0.19, respectively, for subchondral 
bone, subchondral plate, joints space and total score) and 0.19 to 
0.47 for reader 2 (SRM = 0.24, 0.19, 0.32 and 0.47, respectively, 
for subchondral bone, subchondral plate, joints space and total 
score). Joint space seems to be most responsive to both readers 
as well as the total score to reader 2.
DISCUSSION
Successive pathological phases recognised in the course of IP ﬁ  n-
ger joint OA allowed gross changes in the progression of this 
disease to be recorded over a 3-year period.8 9 However, this 
analytical system based on changes in categorical variables did 
not allow discrimination between subtle changes in anatomi-
cal progression occurring within the same phase in shorter time 
studies. Destruction and reconstruction of subchondral bone 
and bone plate, and of the synovial joint space of the affected 
IP joints has shown considerable variation in morbidity and 
occurred much more rapidly than previously recognised.
This study describes the development of a numerical scoring 
system for progression in erosive IP OA. Pathological changes 
occurring in three well-deﬁ  ned tissue compartments when enter-
ing and advancing through the destructive ‘J’ and ‘E’ phases, and 
during periods of repair in the ‘R’ phase were recorded quanti-
tatively on an 11-point rating scale (range 0–100 with 10 unit 
increases). The sum of the three separate scores constituted the 
overall IP joint score.
Cross-sectional and longitudinal intra- and inter-reader 
reproducibility of the three subdomains and the total score 
Table 2  Longitudinal analysis (N=90): mean changes in scores after 6 and 12 months of follow-up, reliability analysis by intraclass coefﬁ  cient of 
correlation, and responsiveness by the smallest detectable change
Variable
Intrareader reliability Inter-reader reliability Responsiveness
  ∆M0–M6 ∆M0–M12 ∆M0–M6 ∆M0–M12 M0–M12   M0–M6  
Reader ICC (95% CI) ICC (95% CI) ICC (95% CI) ICC (95% CI)
Mean ∆ between 
readers (SD) SDC
Mean ∆ between 
readers (SD) SDC
SCh bone 1 0.73 (0.51 to 0.86) 0.75 (0.53 to 0.87) 0.63 (0.36 to 0.81) 0.86 (0.72 to 0.93) 9.3 (12.9) 17.8 14.0 (16.9) 23.5
2 0.99 (0.97 to 0.99) 0.99 (0.99 to 0.99)
SCh plate 1 0.91 (0.83 to 0.96) 0.91 (0.83 to 0.95) 0.87 (0.74 to 0.93) 0.90 (0.81 to 0.95) 10.3 (11.9) 16.5 11.3 (15.5) 21.5
2 0.99 (0.99 to 0.99) 0.99 (0.99 to 0.99)
JT space 1 0.88 (0.76 to 0.94) 0.94 (0.88 to 0.97) 0.83 (0.68 to 0.92) 0.91 (0.81 to 0.96) 13.7 (15.4) 21.4 17.3 (21.0) 29.1
2 0.99 (0.99 to 0.99) 0.99 (0.99 to 0.99)
Total score 1 0.85 (0.71 to 0.93) 0.96 (0.91 to 0.98) 0.86 (0.73 to 0.93) 0.93 (0.86 to 0.97) 26.0 (25.9) 36.0 32.7 (34.3) 47.6
2 0.99 (0.99 to 0.99) 0.99 (0.99 to 1.00)
Reader 1, GV; reader 2, RW.
M0: baseline; M6: month 6; M12: month 12; ∆: change in score; SDC = ±1.96 × SD ∆ (change score)/(√2 × √k); k = 1, if not using average scores.
ICC, intraclass coefﬁ  cient of correlation; JT, joint; SCh, subchondral; SDC, smallest detectable change.
Figure 4  Cumulative probability plot of 1-year radiographic progression. 
Cut-off point was deﬁ  ned by the smallest detectable difference 
(SDC =36.0)—dotted lines. Inset: progression of interphalangeal (IP) 
ﬁ  nger joints through anatomical phases as deﬁ  ned in the categorical 
phase scoring system. Anatomical phases at baseline (T0m) and after 
12 months (T12m) are given. The categorical phase scoring system 
and the Ghent University Scoring System allowed nine and 12 IP joints, 
respectively, to be identiﬁ  ed as remodelled. Eight and nine IP joints were 
recognised as destructive. Anatomical phases: E, erosive; J, joint space 
lost; R, remodelled; S, non-erosive. nr, number of IP ﬁ  nger joints.
Comparison of the categorical anatomical phase scoring system 
and the optimised GUSS
When the categorical anatomical phase scoring system in this IP 
ﬁ  nger joint cohort was used, 10/30 (33.3%) joints were deﬁ  ned 
as progressors from baseline to 6 months: six of these show-
ing further features of destruction and four of obvious repair 
in the selected areas of the joint. With the present scoring sys-
tem, however, signiﬁ  cant disease progression had occurred in 
18 (60.0%) IP joints. More erosive disease or remodelling had 
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were high for both readers. The inter-reader consistency of 
changes in scores over time allowed the SDC to be computed. 
Changes in total score of at least 40 units (SDC = 36.0) over 
12 months and at least 50 units (SDC = 47.6) over 6 months 
represent true changes. The scoring method appeared to be 
sufﬁ  ciently responsive over time within 6-month periods. The 
amount of ‘real’ change that needs to be seen over a shorter 
period (6 months) is, as can be expected, larger than with a 
period of 12 months.
As far as reproducibility and sensitivity to change are con-
cerned, the optimised scoring system for IP ﬁ  nger joint OA per-
forms as well as the original categorical scoring system proposed 
to assess hand OA and its radiological progression.
When the former categorical anatomical phase scoring sys-
tem in the present 30 IP ﬁ  nger joint cohort was used, 56.7% 
joints were deﬁ  ned as progressors after 12 months. With the 
present scoring system, the SDC between 0 and 12 months 
for this series of IP joints allowed signiﬁ  cant disease progres-
sion to be detected in 70.0% of the ﬁ  nger joints. SDC between 
0 and 6 months for the same series of joints enabled disease 
progression to be detected in more than 60.0% of the 30 tar-
get joints, whereas the previous anatomical phase scoring sys-
tem allowed only 33.3% of these IP joints to be classiﬁ  ed as 
progressors.
Within shorter periods of time, the optimised scoring system 
GUSS thus detects the structural modiﬁ  cations that precede a 
change in anatomical phase and may be particularly valuable 
for monitoring natural or drug-modiﬁ  ed disease progression in 
this particular form of OA within shorter time periods and in 
relatively small patient populations. This ﬁ  nding implies a con-
siderable advantage over the classical scoring methods when the 
impact of disease-modifying drugs with anticatabolic and/or repair-
promoting potential are explored. This sensitivity to change of 
the proposed scoring system should be validated in these sorts 
of therapeutic studies.
More importantly, erosive interphalangeal ﬁ  nger joint OA, 
with its biphasic pattern of erosive disease and reparative 
changes, could serve as a clinical model to identify and value 
drugs with disease-modifying potential in other inﬂ  ammatory 
destructive joint diseases.
Currently used scoring systems14 have demonstrated that dis-
ease progression in rheumatoid arthritis and psoriatic arthritis 
is halted by different biological treatments.15 16 Nevertheless, 
repair was only indirectly demonstrated in the affected joints 
in these diseases.17 Undoubtedly, articular structures are all 
affected in a distinctive way in different destructive rheumatic 
joint diseases—for example, in erosive IP ﬁ  nger joint OA, in 
psoriatic arthritis or in rheumatoid arthritis. Using the proposed 
scoring system designed to grade repair in a surrogate disease 
would allow identiﬁ  cation of disease-modifying drugs of possi-
ble use in other systemic joint diseases.
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